Screener
SELLAS Life Sciences Group, Inc. SLS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 6,765 | 7,474 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 350,000,000 shares authorized, 181,332,574 and 153,103,459 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 18 | 15 |
| Additional paid-in capital | 390,789 | 345,844 |
| Accumulated deficit | (283,395) | (274,988) |
| Total stockholders’ equity | 107,412 | 70,871 |
| Total liabilities and stockholders’ equity | $114,177 | $78,345 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s common stock?
- SELLAS Life Sciences Group, Inc. (SLS) reported common stock of $18K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s common stock changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s common stock increased by 100.0% year-over-year, from $9K to $18K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s common stock?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s common stock has grown at a 71.9% compound annual growth rate (CAGR), from $1K to $15K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about SELLAS Life Sciences Group, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude